Newly Diagnosed

Treatment & Care

Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is…

MedMaven

Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is increasing evidence that this may be a good approach.

The Evolving Role of Transplant in Multiple Myeloma in 2019 and Beyond - Dana-Farber Cancer Institute | Boston, MA

The Evolving Role of Transplant in Multiple Myeloma in 2019 and Beyond - Dana-Farber Cancer Institute | Boston, MA

The use of autologous stem cell transplant (ASCT) for selected patients along with the introduction of novel agents has, over the past two decades, markedly improved the median overall survival (OS) of patients to around 7 to 10 years in younger patients.

Comments

Multiple Myeloma

FEATURED

COMMUNITY

Is BCMA The Answer to Treating Multiple Myeloma?

CAR T cells, Bispecific antibodies, and drug conjugates are all being developed to target the B Cell Maturation Antigen.

MedMaven

Supportive Care for Multiple Myeloma

Management of bone complications, anemia, infections and other complications of Multiple Myeloma

Cancer Connect

A New Option for High-risk Multiple Myeloma?

A New Option for High-risk Multiple Myeloma?

Cancer Connect

by

DarkCarder

CAR-T Cell Therapy - Advances in The Management of Multiple Myeloma

ASH 2020 update on CAR-T therapy in multiple myeloma and other targeted therapies. CAR T continues to look promising.

Cancer Connect

Treatment of Recurrent Multiple Myeloma

Cancer Connect - Treatment of Recurrent Multiple Myeloma

Cancer Connect

Sarclisa (isatuximab) – Anti CD38 Targeted Therapy for Myeloma

Sarclisa precision cancer medicine improves survival in advanced Multiple Myeloma - leads to FDA approval

MedMaven

Understanding Maintenance Therapy for Multiple Myeloma

Understand the risks-benefits of Revlimid, Ninlaro & Velcade maintenance therapy for Multiple Myeloma; 2019 ASH update.

Cancer Connect

Ask the Expert Tips: Multiple Myeloma

Sarah Holstein, MD, PhD from Roswell Park Cancer Institute answered questions on multiple myeloma: join the conversation

Cancer Connect

Treatment for Stage II - III Multiple Myeloma

Treatment of stage II-III myeloma may include chemotherapy, precision medicines, stem cell transplant & supportive care.

Cancer Connect

Multiple Myeloma Resources

Useful resources for individuals with Multiple Myeloma

Cancer Connect